ArticleThe archives of bone and joint surgery2026
Cross-Cultural Adaptation, Validity, and Reliability of the Persian Translation of the Merle d'Aubigné-Postel Score.
Article in The archives of bone and joint surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The Merle d'Aubigné--Postel (MDP) score is a widely used patient-reported outcome measure (PROM) for assessing hip function for pain, walking ability, and mobility. Despite its widespread international use, no validated Persian version has been available to date. This study aimed to translate and culturally adapt the MDP score into Persian and evaluate its reliability and validity in Persian-speaking patients undergoing total hip arthroplasty (THA). Methods: Following Guillemin et al. guidelines, Persian translation was done using a forward--backward process, followed by expert review and pretesting with 20 patients to ensure clarity and cultural relevance. The adapted instrument was validated in 103 Persian-speaking patients who had undergone THA with at least one year of follow-up. Internal consistency (Cronbach's alpha), test--retest reliability (intraclass correlation coefficient [ICC]), construct validity (correlation with the Harris Hip Score [HHS]), criterion validity (correlation with HHS and the Western Ontario and McMaster Universities Osteoarthritis Index [WOMAC]), and content validity (floor and ceiling effects) were evaluated. Inter-rater reliability for mobility was assessed by three orthopedic residents. Results: The Persian MDP score demonstrated high internal consistency (α= 0.74) and excellent test--retest reliability (ICC= 0.95; 95%CI: 0.91--0.98). Inter-rater reliability for mobility was excellent (ICC= 0.89; 95%CI: 0.82--0.94). Construct validity was supported by strong domain-specific correlations (e.g., MDP pain vs. HHS pain: r= 0.73; 95%CI: 0.62--0.81). Criterion validity was confirmed by strong correlations with WOMAC (r= 0.745; 95%CI: 0.65--0.82) and HHS (r= 0.753; 95%CI: 0.66--0.83). Content validity showed no floor effect (0%) and an acceptable ceiling effect (14.5%). Conclusion: The Persian MDP score is a valid and reliable instrument for assessing outcomes after THA in Persian-speaking patients. Its simplicity and strong psychometric properties support its use in clinical and research settings. However, the observed ceiling effect should be considered for excellent postoperative outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.